09:50 AM EST - Zomedica Pharmaceuticals Corp. : Has entered into a research collaboration agreement with Celsee Diagnostics, Inc., an innovator of human health products in the emerging field of liquid biopsy. The research project defined in the agreement aims to test the feasibility of Celsee’s liquid biopsy technology for veterinary application as a canine cancer diagnostics. Zomedica Pharmaceuticals Corp.
shares V.ZOM are trading down $0.04 at $1.35.
